Abstract:Objective:To study the relationship between the HBV genotypes and the efficacy of adefovir dipvoxil in treating patients with chronic hepatitis B.Methods:Thirty-seven patients with chronic hepatitis B,who were treated by adefovir dipivoxil 10mg per day for 48 weeks,were selected by expectation.To extract the HBV DNA from the patients blood serum.The surface genes of hepatitis B viruses were amplified by the polymerase chain reaction and sequenced.The relationship of these new S gene sequences to those of the published previously was investigated by constructing a phylogenetic tree,which classified these new S gene sequences into different groups,so it could determine the HBV genotypes.Results:Thirty-seven cases were studied,23 cases were HBV genotype B and 14 cases were HBV genotype C.At the week 48,a decline of at least 2 log10 from baseline HBV DNA was 60.9%(14/23) and 71.4%(10/14) in HBV genotype B and C,the difference is not significant.HBV DNA below the detection limit of 103 copies/ml was 43.5%(10/23)and 42.9%(6/14)in HBV genotype B and C,the difference is not significant.Normalization of ALT levels was 60.9%(14/23)and 71.4%(10/14)in HBV genotype B and C,the difference is not significant.HBeAg nagative and HBeAg seroconversion were 31.8%(7/22)and 9.1%(2/22)in genotype B,38.5%(5/13)and 23.1%(3/13)in genotype C,the difference is not significant.Conclusion:There is no conspicuous association between HBV genotype B,C and the efficancy of adefovir dipivoxil in treating patients with chronic hepatitis B.

Preliminary Study on the Relationship Between HBV Genotypes and the Efficacy of Adefovir Dipvoxil in Chronic Hepatitis B